Key Takeaways

Baxdrostat lowered blood pressure when added to standard treatments for patients with chronic kidney disease and hypertension

The medication also reduced a key marker of kidney and cardiovascular risk in the urine

Baxdrostat works by blocking a hormone that leads to more sodium retention in the body

MONDAY, Sept. 8, 2025 (HealthDay News) — A novel pill that blocks the hormone aldosterone shows promise for lowering blood pressure and potentially delaying the progression of kidney disease in people with both conditions.

The preliminary findings were presented Saturday at an American Heart Association (AHA) meeting in Baltimore and simultaneously published in the Journal of the American Society of Nephrology.

The Phase 2 clinical trial, known as FigHTN, found that the n

See Full Page